Cite
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
MLA
Jakoba J. Eertink, et al. Comparing Lesion and Feature Selections to Predict Progression in Newly Diagnosed DLBCL Patients with FDG PET/CT Radiomics Features. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0956b226791185abf447c19c42bf0723&authtype=sso&custid=ns315887.
APA
Jakoba J. Eertink, Gerben J. C. Zwezerijnen, Matthijs C. F. Cysouw, Sanne E. Wiegers, Elisabeth A. G. Pfaehler, Pieternella J. Lugtenburg, Bronno van der Holt, Otto S. Hoekstra, Henrica C. W. de Vet, Josée M. Zijlstra, & Ronald Boellaard. (2022). Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
Chicago
Jakoba J. Eertink, Gerben J. C. Zwezerijnen, Matthijs C. F. Cysouw, Sanne E. Wiegers, Elisabeth A. G. Pfaehler, Pieternella J. Lugtenburg, Bronno van der Holt, et al. 2022. “Comparing Lesion and Feature Selections to Predict Progression in Newly Diagnosed DLBCL Patients with FDG PET/CT Radiomics Features,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0956b226791185abf447c19c42bf0723&authtype=sso&custid=ns315887.